Stay updated on Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now clearly indicates that recruitment has ended by adding 'No longer looking for participants' and standardizes the 'Intervention/Treatment' header. New help and navigation sections were added ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and the revision tag updated to v3.6.0, signaling a refreshed page presentation.SummaryDifference0.4%

- Check12 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page displays a newer revision label (v3.5.4) replacing the previous one (v3.5.3), indicating a small internal update to the page rendering. The change does not modify the study details or other information shown to users.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page’s site release/revision indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3**.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision identifiers updated from v3.4.3 to v3.5.0. No visible content or data on the study page appears to be changed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Thyroid Cancer Clinical Trial page.